ロサルタンカリウム原薬（API）の世界市場レポート (2025年)

ロサルタンカリウム原薬（API）の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.9%で24億4,000万米ドルに成長します。予測期間中の成長は、慢性疾患を抱える患者人口の拡大、心血管系の予防医療重視の高まり、新興市場におけるヘルスケアサービスの普及拡大、製剤技術の進歩、ジェネリック医薬品を推進する政府のイニシアチブの高まりなどの要因によるものと考えられます。この期間の先進パッケージング動向には、製造プロセスの進歩、先進ドラッグデリバリーシステムの開発、小児に適した製剤の開発、保存期間を延長するための包装技術の革新、ロサルタンを含む併用療法の開発などが含まれます。

高血圧の有病率の上昇は、ロサルタンカリウム原薬（API）市場の成長を促進すると予想されます。高血圧は持続的な高血圧を特徴とする病態であり、心臓病、脳卒中、その他の深刻な健康合併症のリスクを高めます。高血圧の罹患率の増加は、塩分や加工食品の多い食生活が、体液貯留や心臓への負担増加の一因となっていることが主な原因です。ロサルタンカリウムは、血管を収縮させるホルモンであるアンジオテンシンIIを阻害することにより、高血圧を抑制します。血管を弛緩させ広げることで、ロサルタンカリウムは血圧を下げ、心臓の負担を軽減します。例えば、2024年1月、米国心臓協会は、2022年の主な高血圧に関連した死亡者数は13万1,454人で、2021年の12万4,508人から増加したと報告しました。その結果、高血圧の有病率の増加がロサルタンカリウムAPI市場の成長に拍車をかけています。

ロサルタンカリウムAPI市場の企業は、ロサルタンカリウム経口懸濁液のような、患者のコンプライアンスと投与精度を高める革新的な製品の開発に注力しています。この液状のロサルタンカリウムは、錠剤の嚥下が困難な患者向けに設計されています。例えば、2025年3月、米国のバイオ医薬品会社であるサイエンチュア・ホールディングス・インクは、高血圧治療、左室肥大を伴う高血圧患者の脳卒中リスク軽減、2型糖尿病患者の糖尿病性腎症を適応とする、すぐに使用できる液体製剤であるArbliのFDA承認を取得しました。Arbliは、配合剤を必要としない正確な投与が可能で、165mLのペパーミント風味の懸濁液（10mg/mL）で、室温で18ヶ月の保存が可能です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場のマクロ経済シナリオ：金利・インフレ・地政学・貿易戦争・関税・コロナ禍と回復が市場に及ぼす影響を含む

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のロサルタンカリウム原薬（API）市場：PESTEL分析（政治・社会・技術・環境・法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のロサルタンカリウム原薬（API）市場：成長率分析
• 世界のロサルタンカリウム原薬（API）の市場規模・成長率：実績値、2019～2024年
• 世界のロサルタンカリウム原薬（API）の市場規模・成長率：予測値、2024～2029年、2034年
• 世界のロサルタンカリウム原薬（API）市場：総有効市場（TAM）

第6章 市場セグメンテーション

• 世界のロサルタンカリウム原薬（API）市場：製品種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 錠剤
• カプセル
• その他の種類の製品
• 世界のロサルタンカリウム原薬（API）市場：製造方法別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 合成経路
• バイオテクノロジー工程
• 常用フロー生産
• 世界のロサルタンカリウム原薬（API）市場：流通チャネル別、実績値・予測値、2019～2024年、2024～2029年、2034年
• オンライン薬局
• 病院薬局
• 小売薬局
• その他の流通チャネル
• 世界のロサルタンカリウム原薬（API）市場：用途別、実績と予測、実績値・予測値、2019～2024年、2024～2029年、2034年
• 高血圧
• 心不全
• 慢性腎臓病
• その他の用途
• 世界のロサルタンカリウム原薬（API）市場：エンドユーザー別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 病院
• クリニック
• 在宅医療
• 製薬企業
• 世界のロサルタンカリウム原薬（API）市場：錠剤の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 即放錠
• 徐放錠
• フィルムコーティング錠
• 口腔内崩壊錠
• 世界のロサルタンカリウム原薬（API）市場：カプセルの種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• ハードゼラチンカプセル
• ソフトゼラチンカプセル
• 徐放性カプセル
• 世界のロサルタンカリウム原薬（API）市場：その他の製品の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 注射剤
• バルク有効医薬品成分（API）粉末
• 懸濁液用顆粒
• 処方済み中間体

第7章 地域別・国別の分析

• 世界のロサルタンカリウム原薬（API）市場：地域別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 世界のロサルタンカリウム原薬（API）市場：国別、実績値・予測値、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ロサルタンカリウム原薬（API）市場：競合情勢
• ロサルタンカリウム原薬（API）市場：企業プロファイル
  • Teva Pharmaceutical Industries Ltd（概要、製品・サービス、戦略、財務分析）
  • Sun Pharmaceutical Industries Ltd（概要、製品・サービス、戦略、財務分析）
  • Aurobindo Pharma Ltd（概要、製品・サービス、戦略、財務分析）
  • Dr. Reddy's Laboratories（概要、製品・サービス、戦略、財務分析）
  • Cadila Pharmaceuticals Ltd（概要、製品・サービス、戦略、財務分析）

第31章 その他の大手企業と革新的企業

• Lupin Ltd
• Zydus Lifesciences Ltd
• Alkem Laboratories Ltd
• IPCA Laboratories Ltd
• Alembic Pharmaceuticals Ltd
• Granules India Limited
• Vasudha Pharma Chem Ltd
• IOL Chemicals and Pharmaceuticals Limited
• Unichem Laboratories Ltd
• Global Pharma Tek
• Hetero Drugs Ltd
• Manus Aktteva Biopharma LLP
• Wellona Pharma
• Atom pharma
• Sinoway Industrial Co. Ltd

第32章 世界市場：競合ベンチマーキング・ダッシュボード

第33章 主要な企業合併・買収 (M&A)

第34章 最近の市場動向

第35章 市場の潜在力の高い国・部門と戦略

• ロサルタンカリウム原薬（API）市場：最新機会を提供する国（2029年）
• ロサルタンカリウム原薬（API）市場：最新機会を提供する部門（2029年）
• ロサルタンカリウム原薬（API）市場：成長戦略（2029年）
  • 市場動向に基づく戦略
  • 競争戦略

第36章 付録

Losartan potassium active pharmaceutical ingredient (API) refers to the pure compound used in the formulation of losartan-based medications, which are primarily used to treat high blood pressure and protect kidney function. It mainly helps manage hypertension, reduces the risk of heart attacks, and preserves kidney function in diabetic patients.

The main product forms of losartan potassium API include tablets, capsules, and others. Tablets are the most commonly used oral form, valued for their ease of use, affordability, and precise dosing in managing hypertension. It is produced through various methods such as synthetic routes, biotechnological processes, and continuous flow production. Distribution channels include online pharmacies, hospital pharmacies, retail pharmacies, and others. Losartan potassium is used for a range of conditions, including hypertension, heart failure, chronic kidney disease, and more. It is employed by various end-users, such as hospitals, clinics, home care settings, and pharmaceutical companies.

The losartan potassium API market research report is one of a series of new reports from The Business Research Company that provides losartan potassium API market statistics, including the losartan potassium API industry global market size, regional shares, competitors with the losartan potassium API market share, detailed losartan potassium API market segments, market trends, and opportunities, and any further data you may need to thrive in the losartan potassium API industry. This losartan potassium API market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The losartan potassium active pharmaceutical ingredient (API) market size has grown strongly in recent years. It will grow from $1.75 billion in 2024 to $1.87 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth during the historic period can be attributed to factors such as the growing adoption of antihypertensive drugs, the rising incidence of lifestyle-related disorders, increased awareness of cardiovascular health, higher global healthcare expenditure, and the growing demand for affordable generic medications.

The losartan potassium active pharmaceutical ingredient (API) market size is expected to see strong growth in the next few years. It will grow to $2.44 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth during the forecast period can be attributed to factors such as an expanding patient population with chronic illnesses, a growing emphasis on preventive cardiovascular care, increased healthcare service penetration in emerging markets, advancements in drug formulation technologies, and rising government initiatives to promote generic drugs. Key trends during this period include advancements in manufacturing processes, the development of advanced drug delivery systems, the creation of pediatric-friendly formulations, innovations in packaging for extended shelf life, and the development of combination therapies involving losartan.

The rising prevalence of hypertension is expected to drive the growth of the losartan potassium active pharmaceutical ingredient (API) market. Hypertension is a condition characterized by persistently high blood pressure, which increases the risk of heart disease, stroke, and other serious health complications. The growing incidence of hypertension is largely attributed to diets high in salt and processed foods, which contribute to fluid retention and increased strain on the heart. Losartan potassium helps control hypertension by blocking angiotensin II, a hormone that constricts blood vessels. By relaxing and widening blood vessels, losartan potassium lowers blood pressure and reduces the workload on the heart. For instance, in January 2024, the American Heart Association reported that 131,454 deaths were primarily linked to high blood pressure in 2022, a rise from 124,508 deaths in 2021. As a result, the increasing prevalence of hypertension is fueling the growth of the losartan potassium API market.

Companies in the losartan potassium API market are focusing on developing innovative products to enhance patient compliance and precision in dosing, such as losartan potassium oral suspension. This liquid form of losartan potassium is designed for patients who have difficulty swallowing tablets. For example, in March 2025, Scienture Holdings Inc., a US-based biopharmaceutical company, received FDA approval for Arbli, a ready-to-use liquid formulation for hypertension treatment, stroke risk reduction in hypertensive patients with left ventricular hypertrophy, and diabetic nephropathy in type 2 diabetes patients. Arbli offers precise dosing without the need for compounding and comes in a 165 mL peppermint-flavored suspension (10 mg/mL) with an 18-month shelf life at room temperature.

In April 2025, Scienture Holdings Inc., a US-based pharmaceutical company, formed a partnership with Saptalis Pharmaceuticals LLC to manufacture Arbli (losartan potassium) Oral Suspension, 10 mg/mL. The collaboration includes warehousing and distribution agreements to ensure market readiness for the first FDA-approved ready-to-use oral liquid losartan, addressing unmet needs in hypertension treatment. Saptalis Pharmaceuticals LLC, a US-based pharmaceutical company, specializes in developing and distributing losartan potassium formulations.

Major players in the losartan potassium active pharmaceutical ingredient (API) market are Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Dr. Reddy's Laboratories, Cadila Pharmaceuticals Ltd, Lupin Ltd, Zydus Lifesciences Ltd, Alkem Laboratories Ltd, IPCA Laboratories Ltd, Alembic Pharmaceuticals Ltd, Granules India Limited, Vasudha Pharma Chem Ltd, IOL Chemicals and Pharmaceuticals Limited, Unichem Laboratories Ltd, Global Pharma Tek, Hetero Drugs Ltd, Manus Aktteva Biopharma LLP, Wellona Pharma, Atom pharma, Sinoway Industrial Co. Ltd, Cerata Pharmaceuticals LLP.

North America was the largest region in the losartan potassium API market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in losartan potassium active pharmaceutical ingredient (API) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the losartan potassium active pharmaceutical ingredient (API) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The losartan potassium active pharmaceutical ingredient (API) market consists of sales of bulk powder, granules, injectable concentrates, and pre-formulated intermediates. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Losartan Potassium Active Pharmaceutical Ingredient (API) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on losartan potassium active pharmaceutical ingredient (api) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for losartan potassium active pharmaceutical ingredient (api) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The losartan potassium active pharmaceutical ingredient (api) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Tablet; Capsule; Other Product Types
• 2) By Production Method: Synthetic Route; Biotechnological Process; Continuous Flow Production
• 3) By Distribution Channel: Online Pharmacies; Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
• 4) By Application: Hypertension; Heart Failure; Chronic Kidney Diseases; Other Applications
• 5) By End-User: Hospitals; Clinics; Home Care Settings; Pharmaceutical Companies
• Subsegments:
• 1) By Tablet: Immediate-Release Tablets; Extended-Release Tablets; Film-Coated Tablets; Orally Disintegrating Tablets
• 2) By Capsule: Hard Gelatin Capsules; Soft Gelatin Capsules; Modified-Release Capsules
• 3) By Other Product Types: Injectable Formulations; Bulk Active Pharmaceutical Ingredient (API) Powder; Granules For Suspension; Pre-Formulated Intermediates
• Companies Mentioned: Teva Pharmaceutical Industries Ltd; Sun Pharmaceutical Industries Ltd; Aurobindo Pharma Ltd; Dr. Reddy's Laboratories; Cadila Pharmaceuticals Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Losartan Potassium Active Pharmaceutical Ingredient (API) Market Characteristics

3. Losartan Potassium Active Pharmaceutical Ingredient (API) Market Trends And Strategies

4. Losartan Potassium Active Pharmaceutical Ingredient (API) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Losartan Potassium Active Pharmaceutical Ingredient (API) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Losartan Potassium Active Pharmaceutical Ingredient (API) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market Growth Rate Analysis
• 5.4. Global Losartan Potassium Active Pharmaceutical Ingredient (API) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Losartan Potassium Active Pharmaceutical Ingredient (API) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Losartan Potassium Active Pharmaceutical Ingredient (API) Total Addressable Market (TAM)

6. Losartan Potassium Active Pharmaceutical Ingredient (API) Market Segmentation

• 6.1. Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablet
• Capsule
• Other Product Types
• 6.2. Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Synthetic Route
• Biotechnological Process
• Continuous Flow Production
• 6.3. Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online Pharmacies
• Hospital Pharmacies
• Retail Pharmacies
• Other Distribution Channels
• 6.4. Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hypertension
• Heart Failure
• Chronic Kidney Diseases
• Other Applications
• 6.5. Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Home Care Settings
• Pharmaceutical Companies
• 6.6. Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Sub-Segmentation Of Tablet, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immediate-Release Tablets
• Extended-Release Tablets
• Film-Coated Tablets
• Orally Disintegrating Tablets
• 6.7. Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Sub-Segmentation Of Capsule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hard Gelatin Capsules
• Soft Gelatin Capsules
• Modified-Release Capsules
• 6.8. Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Formulations
• Bulk Active Pharmaceutical Ingredient (API) Powder
• Granules For Suspension
• Pre-Formulated Intermediates

7. Losartan Potassium Active Pharmaceutical Ingredient (API) Market Regional And Country Analysis

• 7.1. Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 8.1. Asia-Pacific Losartan Potassium Active Pharmaceutical Ingredient (API) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 9.1. China Losartan Potassium Active Pharmaceutical Ingredient (API) Market Overview
• 9.2. China Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 10.1. India Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 11.1. Japan Losartan Potassium Active Pharmaceutical Ingredient (API) Market Overview
• 11.2. Japan Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 12.1. Australia Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 13.1. Indonesia Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 14.1. South Korea Losartan Potassium Active Pharmaceutical Ingredient (API) Market Overview
• 14.2. South Korea Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 15.1. Western Europe Losartan Potassium Active Pharmaceutical Ingredient (API) Market Overview
• 15.2. Western Europe Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 16.1. UK Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 17.1. Germany Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 18.1. France Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 19.1. Italy Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 20.1. Spain Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 21.1. Eastern Europe Losartan Potassium Active Pharmaceutical Ingredient (API) Market Overview
• 21.2. Eastern Europe Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 22.1. Russia Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 23.1. North America Losartan Potassium Active Pharmaceutical Ingredient (API) Market Overview
• 23.2. North America Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 24.1. USA Losartan Potassium Active Pharmaceutical Ingredient (API) Market Overview
• 24.2. USA Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 25.1. Canada Losartan Potassium Active Pharmaceutical Ingredient (API) Market Overview
• 25.2. Canada Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 26.1. South America Losartan Potassium Active Pharmaceutical Ingredient (API) Market Overview
• 26.2. South America Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 27.1. Brazil Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 28.1. Middle East Losartan Potassium Active Pharmaceutical Ingredient (API) Market Overview
• 28.2. Middle East Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Losartan Potassium Active Pharmaceutical Ingredient (API) Market

• 29.1. Africa Losartan Potassium Active Pharmaceutical Ingredient (API) Market Overview
• 29.2. Africa Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Production Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Losartan Potassium Active Pharmaceutical Ingredient (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Losartan Potassium Active Pharmaceutical Ingredient (API) Market Competitive Landscape And Company Profiles

• 30.1. Losartan Potassium Active Pharmaceutical Ingredient (API) Market Competitive Landscape
• 30.2. Losartan Potassium Active Pharmaceutical Ingredient (API) Market Company Profiles
  • 30.2.1. Teva Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sun Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Aurobindo Pharma Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Dr. Reddy's Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Cadila Pharmaceuticals Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Losartan Potassium Active Pharmaceutical Ingredient (API) Market Other Major And Innovative Companies

• 31.1. Lupin Ltd
• 31.2. Zydus Lifesciences Ltd
• 31.3. Alkem Laboratories Ltd
• 31.4. IPCA Laboratories Ltd
• 31.5. Alembic Pharmaceuticals Ltd
• 31.6. Granules India Limited
• 31.7. Vasudha Pharma Chem Ltd
• 31.8. IOL Chemicals and Pharmaceuticals Limited
• 31.9. Unichem Laboratories Ltd
• 31.10. Global Pharma Tek
• 31.11. Hetero Drugs Ltd
• 31.12. Manus Aktteva Biopharma LLP
• 31.13. Wellona Pharma
• 31.14. Atom pharma
• 31.15. Sinoway Industrial Co. Ltd

32. Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Losartan Potassium Active Pharmaceutical Ingredient (API) Market

34. Recent Developments In The Losartan Potassium Active Pharmaceutical Ingredient (API) Market

35. Losartan Potassium Active Pharmaceutical Ingredient (API) Market High Potential Countries, Segments and Strategies

• 35.1 Losartan Potassium Active Pharmaceutical Ingredient (API) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Losartan Potassium Active Pharmaceutical Ingredient (API) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Losartan Potassium Active Pharmaceutical Ingredient (API) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer